Is Stem Cell Therapy Right for Your Knee Osteoarthritis? A Candidacy Guide

If you’ve been told you have knee osteoarthritis, you’ve probably already come across the phrase “stem cell therapy” while researching your options. It’s a term that gets used loosely online, often alongside promises that sound too good to be true.

Before considering stem cell therapy for knee osteoarthritis, you need a clear, honest answer to one question. Is this treatment appropriate for the specific stage of arthritis in your knee?

That answer depends on how advanced your joint damage is — and that’s exactly what this guide walks you through.

The Problem: Living with Knee Osteoarthritis and Weighing Your Options

Knee osteoarthritis develops gradually. Many patients describe the same pattern: stiffness first thing in the morning, a dull ache after a long day on their feet. Over time, this often grows into a hesitation around stairs or long walks.

Some have already tried physiotherapy, weight management, and anti-inflammatory medication with only partial relief. Others have been told that a knee replacement is “in the future” but aren’t ready for surgery yet. They want to know what — if anything — can be done in the meantime.

It’s natural to have questions before considering any newer treatment, especially one you’ve mostly encountered through advertisements or social media rather than a medical consultation. A common concern patients raise is whether stem cell therapy can genuinely help arthritis, or whether it only works for younger patients with milder joint wear.

What Is Stem Cell Therapy for Knee Osteoarthritis?

Stem cell therapy for the knee typically involves concentrating cells with regenerative potential. These are usually drawn from the patient’s own bone marrow or fat tissue, then injected into the joint. The intent is to influence the joint’s inflammatory environment and support the health of the remaining cartilage, rather than to regrow a worn-out joint surface entirely.

It’s important to separate this from cartilage transplantation or joint replacement, which are different procedures altogether. Stem cell therapy sits within the broader category of joint preservation procedures — options considered before more invasive surgery becomes necessary, not a substitute for it once damage is advanced. It’s one part of a wider regenerative medicine approach used alongside other options depending on what a patient’s joint actually needs.

The scientific evidence in this area is still developing. Some patients with early-to-moderate osteoarthritis report meaningful improvement in pain and function. Results in advanced, “bone-on-bone” arthritis tend to be more limited, since there is little healthy cartilage left for the treatment to support.

It’s also worth knowing where this stands in India specifically. The Indian Council of Medical Research’s evidence-basedguidelines currently classify stem cell therapy for orthopaedic conditions as not yet a standard or routine therapy. That means it isn’t a default first-line treatment, but one considered on a case-by-case basis.

ICMR’s own review of the published evidence found mostly small studies. One 56-patient trial, for example, found stem cells performed better than a comparison injection when combined with corrective knee surgery.

That trial wasn’t blinded, though, and ICMR’s assessment is that evidence at this level doesn’t yet meet the bar for standard use. This is precisely why candidacy assessment matters more than the procedure itself.

Who Is a Good Candidate for Stem Cell Therapy for Knee Osteoarthritis?

Candidacy for stem cell therapy in knee osteoarthritis is generally assessed against a few factors:

• Severity of joint damage, staged the same way as our clinic’s other resources (Grade 1–4).Grade 1 (very mild wear) through early Grade 3 (moderate cartilage loss, some healthy tissue remaining) are generally the better candidates. By Grade 4 — bone-on-bone arthritis — there’s little healthy cartilage left for stem cell therapy to support, and joint replacement typically becomes the more effective option.
• Response to conservative treatment.Most patients considering this option have already tried physiotherapy, weight management, activity modification, or medication.
• Overall joint alignment and stability.Significant deformity or ligament instability may need to be addressed separately, or may reduce how much benefit regenerative treatment alone can offer.
• General health factors, since certain medical conditions and medications can affect suitability.

None of this can be assessed from a description alone — it requires a clinical examination and imaging to see exactly how much cartilage and joint space remain.

A treatment plan should never be built around a single online description of “stem cell therapy.” The right approach depends entirely on your knee, not a generic protocol. See our full overview of knee osteoarthritistreatment options for how this fits alongside conservative care and surgery.

What does a candidacy assessment actually involve?
While the exact process varies by clinic, a thorough candidacy assessment for stem cell therapy generally includes a few consistent steps. First, a review of your symptom history and what conservative treatments you’ve already tried. Second, a physical examination of the knee’s alignment, stability, and range of motion. Third, imaging — typically an X-ray, sometimes an MRI — to see the actual extent of cartilage loss and joint space narrowing.

Only after these three steps can severity be graded and candidacy genuinely assessed, rather than assumed from symptoms alone. For a closer look at how arthritis severity is staged and what non-surgical options exist at each stage, see CanKnee Arthritis Be Treated Without Surgery?

Who should not consider stem cell therapy?
Stem cell therapy is not for everyone. Several health and lifestyle factors can make stem cell therapy unsuitable or complicate it further — each one is weighed case-by-case during your evaluation, not applied as a blanket rule:

• Any history of cancer, whether active or previously treated.Stem cell therapy works by encouraging cell growth to support healing. That same growth-promoting effect could, in theory, also encourage the growth of cancer cells. Because of this risk, any history of cancer rules out candidacy, regardless of how long ago it was treated.

• Active systemic infection.An infection anywhere in the body raises the risk of introducing it into the joint during injection, and can interfere with how well the treatment works. Any active infection needs to be treated and resolved first.

• Blood disorders or clotting issues.Certain blood conditions, or medications that affect clotting, complicate both the process of harvesting cells and the injection itself.

• Advanced organ failure or serious systemic disease.Significant heart, kidney, liver, or other organ dysfunction can make the harvesting and treatment process unsafe, independent of what’s happening in the knee.

• Skeletal immaturity, or advanced age with frailty.Patients whose bones are still developing aren’t candidates for joint procedures like this one. At the other end of the spectrum, significant frailty can shift the overall risk-benefit balance.

Eligibility isn’t only about physical health, though. It’s also shaped by lifestyle, and by a patient’s ability to follow through on what comes after treatment. Heavy smoking is one clear example — nicotine narrows blood vessels and has been shown to impair how stem cells function, working against the very process the treatment depends on.

Recovery also depends on genuine commitment to structured rehabilitation. Regenerative treatment typically requires mechanical loading — controlled, guided stress on the joint through physical therapy — along with specific activity modifications, to help the treated tissue respond correctly.

Patients who can’t commit to this rehabilitation phase often don’t see the functional improvement they were hoping for, regardless of how well the treatment itself was performed.

Is Stem Cell Therapy Safe, and When Should You Seek Care?

Stem cell therapy using a patient’s own cells is generally well-tolerated. The main short-term effects are mild soreness or swelling at the injection site, similar to other joint injections. As with any joint procedure, it should be performed in a proper clinical setting with appropriate sterile technique to minimise infection risk.

It’s worth being cautious of any clinic or advertisement that guarantees cartilage regrowth, promises to “cure” arthritis, or presents this as a universal alternative to surgery for every patient. Responsible practice means being upfront that this treatment has a role for some patients and not others, and that expectations should be realistic and specific to your joint.

If you experience worsening pain, fever, or significant swelling after any joint procedure, this needs prompt medical attention rather than waiting it out.

Frequently Asked Questions

Can stem cell therapy help knee arthritis?
It can help some patients, particularly those with early-to-moderate osteoarthritis who still have some healthy cartilage and joint space remaining. The degree of benefit varies by individual, and it isn’t intended as a universal fix for every stage of arthritis.

How effective is stem cell therapy for knee arthritis?
Reported outcomes vary across patients and depend heavily on the severity of arthritis at the time of treatment. Earlier-stage cases with more preserved cartilage generally see more meaningful improvement than advanced, bone-on-bone cases. A clinical evaluation is the only reliable way to estimate what to expect in your specific case.

How does stem cell injection help knee arthritis?
The injected cells are thought to influence the joint’s inflammatory environment and support the health of remaining cartilage tissue. It’s a joint-preservation approach rather than a way to regenerate cartilage that has already been lost.

Is stem cell therapy the same as a knee replacement?
No. Stem cell therapy is generally considered earlier in the treatment journey, for patients who still have joint-preserving options available. Once arthritis is advanced and cartilage loss is extensive, joint replacement typically becomes the more appropriate option. Even so, the right choice still depends on your overall health, function, and preferences, not on X-rays alone.